Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2020 Aug 20;64(9):e01351-20. doi: 10.1128/AAC.01351-20

Erratum for Amblard et al., “Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice”

Franck Amblard a, Sebastien Boucle a, Leda Bassit a, Bryan Cox a, Ozkan Sari a, Sijia Tao a, Zhe Chen a, Tugba Ozturk a, Kiran Verma a, Olivia Russell a, Virgile Rat b, Hugues de Rocquigny b, Oriane Fiquet c,d, Maud Boussand c,d, James Di Santo c,d, Helene Strick-Marchand c,d, Raymond F Schinazi a,
PMCID: PMC7449178  PMID: 32819965

ERRATUM

Volume 64, no. 2, e01701-19, 2020, https://doi.org/10.1128/AAC.01701-19. Acknowledgments: the following conflict of interest declarations should be included in the Acknowledgments section. “R. F. Schinazi, F. Amblard, and L. Bassit along with Emory University are entitled to equity and royalties related to products licensed to Aligos Therapeutics, Inc., being further evaluated in the research described in this paper. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.”


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES